Get Free Access
TZ Ref No.: TZ-1195469

33600000-0 pharmaceutical products (ambroxol, solution for injection/infusion 7.5 mg/ml, in 2 ml; methazolic sodium, solution to injection 500 mg/mL, in two ml; ascorbic acid solutions for injections 100 mg/ ml, in one ml; barbiturates in...

Doc ref no. -
Sector Pharmaceuticals, Healthcare Equipment and Services, Healthcare and Medicine
Publish Date 14 Oct 2026
Estimated Value UAH 69K
Tender Intelligence
Qualification analysis + key highlights for this procurement

TenderZenith matches this tender's eligibility criteria against your company profile to calculate a deterministic qualification score and identify potential disqualifiers.

A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.

Sign in to unlock Bid Fit & AI Opportunity Intelligence

TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).

Description & Project Overview

33600000-0 pharmaceutical products (ambroxol, solution for injection/infusion 7.5 mg/ml, in 2 ml; methazolic sodium, solution to injection 500 mg/mL, in two ml; ascorbic acid solutions for injections 100 mg/ ml, in one ml; barbiturates in combination (ethyl ether a-bromized hyaluronic acid 18 mg, phenobarbital 17 mg, menthol solution in mentil ether isoheluronic acids 80 mg) oral solutions 25 ml; thiamine chloride (vitamin B1), solutions for injecting 50 mg/mol, in 1 ml; deoxygenated drugs (injected into solution 40 mg/mil; 50 mg for injectioneering, injected injectation, in 20 ml/ml; 50 ml for injectable solution, inhalation, in solution 20 ml; 50 g/ml for injectables; 50 mL for injects, injection, in 5 ml/m; 20 ml for injections, in injections, for injected into solution 20 mg/mo;40 mg; pantoprazol tablets 40 mg, chlorithromycin tablets, coated with a coating, 500 mg; barbiturates in combination (20 mg of ethyl ether of a-bromizolate chloride acid, 18.26 mg of phenobarbital, 1.42 mg of lime oil) 25 ml oral drops; linoleic tablets coated in a coat, 600 mg; magnesium sulfate, solution for injection, 250 mg/ ml, 5 ml; meloxycin solutions for injections 10 mg/ml, 1.5 ml; melancholic solutions for injectation 100 mg/ML, 5ml; pilufoxyl toxin tablets in a capsule; 20 mg/mm, 20 mg, 20 ml, 20 mm, 20 mL; 5 mg/mL, 20ml, 20mg, 20mm, 500 ml, for injects of hydrolysis, 20 μl; 5 ml, 50 ml, and 20 ml for injectable, 20

Days to Deadline
27 days
Closing: 13 Nov 2026, 00:00

Consortium & JV Partners

Matched
Need a Co-Bidder or Subcontractor?

Forming a Joint Venture increases technical eligibility and financial bonding capacity.

Post / Find JV Partners →

Key Procurement Details

Doc ref no. -
Notice Type Tender Notice
Bidding Type N/A
Publish Date 14 Oct 2026
Sector Pharmaceuticals, Healthcare Equipment and Services, Healthcare and Medicine
Document Fee Available in full notice
Bid Security Refer to documents
Funding Government Budget
Bid Opening Locked

Buyer Contact Information

Contact Details Locked

Nodal officer email, telephone, and website coordinates are unlocked upon free sign up.

Unlock Contact Details (Free) →